Health Care XORTX (TSXV:XRTX) closes US$5M public offering XORTX Therapeutics (XRTX) has closed its public offering for gross proceeds of up to $5,000,000The offering consists... John Ballem1 min11 October 2022 08:30 (EDT)
Health Care The Market Online Deal Room XORTX (TSXV:XRTX) announces US$5M public offering XORTX Therapeutics (XRTX) has announced the pricing of an underwritten public offering for gross proceeds of... John Ballem1 min04 October 2022 09:15 (EDT)
Health Care XORTX (TSXV:XRTX) oral drug yields positive results XORTX Therapeutics Inc. (XRTX) has reported positive results from part two of its pharmacokinetics bridging study... Caroline Egan2 mins22 August 2022 13:30 (EDT)
Health Care XORTX (TSXV:XRTX) submits request to EMA for medicinal products for human use XORTX Therapeutics (XRTX) has submitted a request for scientific advice review to the European Medicines Agency... Jonathon Brown2 mins19 July 2022 13:45 (EDT)
Health Care XORTX (TSXV:XRTX) sees positive topline results from Pharmacokinetics Bridging Clinical Trial XORTX Therapeutics (XRTX) announced positive topline results from the first of its three part Pharmacokinetics Bridging... Jonathon Brown1 min13 July 2022 17:00 (EDT)
Health Care XORTX (TSXV:XRTX) opens an IND for XRx-008 program for autosomal dominant polycystic kidney disease XORTX Therapeutics (XRTX) has received official notification from the US Food and Drug Association (FDA) The... Azuka Onwuka3 mins05 May 2022 10:45 (EDT)
Health Care XORTX (TSXV:XRTX) receives Small and Medium Enterprise (SME) status XORTX Therapeutics Inc. (XRTX) receives Small and Medium Enterprise (SME) status for the European UnionThis status... Caroline Egan2 mins20 April 2022 14:15 (EDT)
Health Care XORTX Therapeutics (TSXV:XRTX) announces grant of U.S. patent XORTX Therapeutics has announced the receipt of notification that the patent “Formulations of Xanthine Oxidase Inhibitors”... Azuka Onwuka2 mins07 April 2022 14:30 (EDT)
Health Care XORTX (TSXV:XRTX) seeks international patent protection XORTX Therapeutics Inc. (XRTX) has applied for international protection for its patent entitled “Compositions and Methods... Caroline Egan2 mins23 March 2022 15:45 (EDT)
Health Care XORTX Therapeutics (TSXV:XTRX) applies to conduct bridging clinical study XORTX Therapeutics Inc. (XRTX) has submitted a clinical trial application (CTA) with Health Canada for a... Caroline Egan2 mins14 March 2022 13:45 (EDT)
